Multivendor Trial in Spinal Cord Stimulation

Multivendor Trial in Spinal Cord Stimulation - Multivendor SCS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00027970

Enrollment

Registered

2022-02-03

Start date

2022-02-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R52.1

Interventions

Group 1: Trial stimulation with external pulse generator of Abbott for 7 days Group 2: Trial stimulation with external pulse generator of Boston Scientific for 7 days

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Implantation of an Abbott test lead for spinal cord stimulation trial. 2. Pain intensity of more than 5 on visual analog scale for more than 3 months. 3. The patient has the ability to read, understand and give information reliably as required by the protocol.

Exclusion criteria

Exclusion criteria: 1. Patients with another pain disorder, which could influence the study results 2. Adults unable to give consent 3. Children and adolescents

Design outcomes

Primary

Measure	Time frame
Trial-to-implant ratio	—

Secondary

Measure	Time frame
Following parameters are evaluated at the end of each test phase: pain intensity (visual analog scale), coverage of the painful area (German Pain Questionnaire), analgesics intake (patient's diary), patient satisfaction (Clinical Global Impression)	—

Countries

Germany

Contacts

Public ContactGuilherme Santos Piedade

Universitätsklinikum Düsseldorf

guilherme.santospiedade@med.uni-duesseldorf.de02118116058

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026